P/E společnosti Midatech Pharma Plc
Jaká je hodnota metriky P/E společnosti Midatech Pharma Plc?
Hodnota metriky P/E společnosti Midatech Pharma Plc je N/A
Jaká je definice metriky P/E?
P/E ratio je koeficient daný poměrem ceny akcie a příjmu společnosti na akcii za posledních 12 měsíců.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E společností v sektoru Health Care sektor na LSE ve srovnání se společností Midatech Pharma Plc
Čemu se věnuje společnost Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Firmy s metrikou p/e podobnou společnosti Midatech Pharma Plc
- Hodnota metriky P/E společnosti UMT United Mobility Technology AG je N/A
- Hodnota metriky P/E společnosti Alberton Acquisition je N/A
- Hodnota metriky P/E společnosti Evergold je N/A
- Hodnota metriky P/E společnosti Evergold Corp je N/A
- Hodnota metriky P/E společnosti Teladoc Health je N/A
- Hodnota metriky P/E společnosti TRU Precious Metals je N/A
- Hodnota metriky P/E společnosti Midatech Pharma Plc je N/A
- Hodnota metriky P/E společnosti Rite Aid je N/A
- Hodnota metriky P/E společnosti OCL Iron and Steel je N/A
- Hodnota metriky P/E společnosti Power Projects je N/A
- Hodnota metriky P/E společnosti MAS Gold je N/A
- Hodnota metriky P/E společnosti Freshlocal Solutions je N/A
- Hodnota metriky P/E společnosti Woodbridge Ventures je N/A